Mostrar el registro sencillo del ítem

dc.contributor.author
Choi, Angela  
dc.contributor.author
Ibañez, Lorena Itatí  
dc.contributor.author
Strohmeier, Shirin  
dc.contributor.author
Krammer, Florian  
dc.contributor.author
García Sastre, Adolfo  
dc.contributor.author
Schotsaert, Michael  
dc.date.available
2022-02-18T15:26:08Z  
dc.date.issued
2020-06  
dc.identifier.citation
Choi, Angela; Ibañez, Lorena Itatí; Strohmeier, Shirin; Krammer, Florian; García Sastre, Adolfo; et al.; Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses; Frontiers Media; Frontiers in Immunology; 11; 1166; 6-2020; 1-18  
dc.identifier.issn
1664-3224  
dc.identifier.uri
http://hdl.handle.net/11336/152307  
dc.description.abstract
Conventional influenza vaccines aim at the induction of virus-neutralizing antibodies that provide with sterilizing immunity. However, influenza vaccination often confers protection from disease but not from infection. The impact of infection-permissive vaccination on the immune response elicited by subsequent influenza virus infection is not well-understood. Here, we investigated to what extent infection-permissive immunity, in contrast to virus-neutralizing immunity, provided by a trivalent inactivated virus vaccine (TIV) modulates disease and virus-induced host immune responses after sublethal vaccine-matching H1N1 infection in a mouse model. More than one TIV vaccination was needed to induce a serum HI titer and provide sterilizing immunity upon homologous virus infection. However, single TIV administration provided infection-permissive immunity, characterized by lower viral lung titers and faster recovery. Despite the presence of replicating virus, single TIV vaccination prevented induction of pro-inflammatory cyto- and chemokines, alveolar macrophage depletion as well as the establishment of lung-resident B and T cells after infection. To investigate virus infection-induced cross-protective heterosubtypic immune responses in vaccinated and unvaccinated animals, mice were re-infected with a lethal dose of H3N2 virus 4 weeks after H1N1 infection. Single TIV vaccination did not prevent H1N1 virus infection-induced heterosubtypic cross-protection, but shifted the mechanism of cross-protection from the cellular to the humoral branch of the immune system. These results suggest that suboptimal vaccination with conventional influenza vaccines may still positively modulate disease outcome after influenza virus infection, while promoting humoral heterosubtypic immunity after virus infection.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Frontiers Media  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ALVEOLAR MACROPHAGE  
dc.subject
GERMINAL CENTER B CELL  
dc.subject
HETEROSUBTYPIC IMMUNITY  
dc.subject
INFLUENZA  
dc.subject
PRE-EXISTING IMMUNITY  
dc.subject
TISSUE-RESIDENT MEMORY T CELL  
dc.subject
TIV  
dc.subject.classification
Virología  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2021-04-28T21:37:06Z  
dc.journal.volume
11  
dc.journal.number
1166  
dc.journal.pagination
1-18  
dc.journal.pais
Suiza  
dc.description.fil
Fil: Choi, Angela. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.description.fil
Fil: Ibañez, Lorena Itatí. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología "Dr. César Milstein"; Argentina  
dc.description.fil
Fil: Strohmeier, Shirin. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.description.fil
Fil: Krammer, Florian. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.description.fil
Fil: García Sastre, Adolfo. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.description.fil
Fil: Schotsaert, Michael. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.journal.title
Frontiers in Immunology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/article/10.3389/fimmu.2020.01166/full  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fimmu.2020.01166